QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 19, Issue 3, 1210-1219, March 2008

This Article Full Text Full Text (PDF) Supplemental Materials All Versions of this Article: E07-09-0965v1 19/3/1210    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Narala, S. R. Articles by Vaziri, H. Search for Related Content PubMed PubMed Citation Articles by Narala, S. R. Articles by Vaziri, H.

SIRT1 Acts as a Nutrient-sensitive Growth Suppressor and Its Loss Is Associated with Increased AMPK and Telomerase Activity

Swami R. Narala^*, Richard C. Allsopp, Trystan B. Wells^*, Guanglei Zhang^*, Prerna Prasad, Matthew J. Coussens, Derrick J. Rossi, Irving L. Weissman, and Homayoun Vaziri^*

*Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G-2M9, Canada; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305; and Institute for Biogenesis Research, University of Hawaii, Honolulu, HI 96813

Submitted September 25, 2007; Revised December 1, 2007; Accepted December 27, 2007
Monitoring Editor: Wendy Bickmore

SIRT1, the mammalian homolog of SIR2 in Saccharomyces cerevisiae, is an NAD-dependent deacetylase implicated in regulation of lifespan. By designing effective short hairpin RNAs and a silent shRNA-resistant mutant SIRT1 in a genetically defined system, we show that efficient inhibition of SIRT1 in telomerase-immortalized human cells enhanced cell growth under normal and nutrient limiting conditions. Hematopoietic stem cells obtained from SIRT1-deficient mice also showed increased growth capacity and decreased dependency on growth factors. Consistent with this, SIRT1 inhibition was associated with increased telomerase activity in human cells. We also observed a significant increase in AMPK levels up on SIRT1 inhibition under glucose limiting conditions. Although SIRT1 suppression cooperated with hTERT to promote cell growth, either overexpression or suppression of SIRT1 alone had no effect on life span of human diploid fibroblasts. Our findings challenge certain models and connect nutrient sensing enzymes to the immortalization process. Furthermore, they show that in certain cell lineages, SIRT1 can act as a growth suppressor gene.

Address correspondence to: Homayoun Vaziri (vaziri{at}oci.utoronto.ca)

This article has been cited by other articles:

				J.-H. Um, S.-J. Park, H. Kang, S. Yang, M. Foretz, M. W. McBurney, M. K. Kim, B. Viollet, and J. H. Chung AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol Diabetes, March 1, 2010; 59(3): 554 - 563. [Abstract] [Full Text] [PDF]

				V. B. Pillai, N. R. Sundaresan, G. Kim, M. Gupta, S. B. Rajamohan, J. B. Pillai, S. Samant, P. V. Ravindra, A. Isbatan, and M. P. Gupta Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway J. Biol. Chem., January 29, 2010; 285(5): 3133 - 3144. [Abstract] [Full Text] [PDF]

				S. B. Shears Diphosphoinositol Polyphosphates: Metabolic Messengers? Mol. Pharmacol., August 1, 2009; 76(2): 236 - 252. [Abstract] [Full Text] [PDF]

				N. Kabra, Z. Li, L. Chen, B. Li, X. Zhang, C. Wang, T. Yeatman, D. Coppola, and J. Chen SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer J. Biol. Chem., July 3, 2009; 284(27): 18210 - 18217. [Abstract] [Full Text] [PDF]

				J. Yuan, K. Minter-Dykhouse, and Z. Lou A c-Myc-SIRT1 feedback loop regulates cell growth and transformation J. Cell Biol., April 20, 2009; 185(2): 203 - 211. [Abstract] [Full Text] [PDF]

				J. D. Erusalimsky Vascular endothelial senescence: from mechanisms to pathophysiology J Appl Physiol, January 1, 2009; 106(1): 326 - 332. [Abstract] [Full Text] [PDF]